Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-02-21
DOI
10.1093/eurheartj/ehz119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study
- (2018) MaryAnn Zhang et al. CIRCULATION
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
- (2018) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities (CARES) trial and associated FDA public safety alert
- (2018) Hyon Choi et al. Arthritis & Rheumatology
- Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
- (2018) Kenjiro Kimura et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels
- (2018) Daniel H. Solomon et al. ANNALS OF INTERNAL MEDICINE
- Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia
- (2017) Sunao Kojima et al. Journal of Cardiology
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis
- (2016) Min Li et al. Scientific Reports
- Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial
- (2015) Kenichi Tanaka et al. Clinical and Experimental Nephrology
- Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction
- (2014) Yugo Shibagaki et al. HYPERTENSION RESEARCH
- The role of serum uric acid in cardiovascular disease in Type 2 diabetic and non-diabetic subjects: A narrative review
- (2014) G. Zoppini et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
- (2013) Akira Sezai et al. CIRCULATION JOURNAL
- Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
- (2013) Bhadran Bose et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Chapter 1: Definition and classification of CKD
- (2012) Kidney International Supplements
- Association of albuminuria and reduced estimated glomerular filtration rate with incident stroke and coronary artery disease in patients with type 2 diabetes
- (2010) Ryotaro Bouchi et al. HYPERTENSION RESEARCH
- Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout
- (2010) E. Krishnan RHEUMATOLOGY
- Prevalence of chronic kidney disease in the Japanese general population
- (2009) Enyu Imai et al. Clinical and Experimental Nephrology
- Uric Acid and Incident Kidney Disease in the Community
- (2008) D. E. Weiner et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Elevated Uric Acid Increases the Risk for Kidney Disease
- (2008) R. P. Obermayr et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More